Treatment for recurrent vulvovaginal candidiasis (thrush)
Cooke G, et al
Published in Cochrane Database Syst Rev
Key Findings
Antifungal maintenance regimens reduce recurrence of vulvovaginal candidiasis, but evidence for complementary treatments is low certainty.
Conclusions
Antifungals remain first-line; non-drug options lack reliable supporting evidence.
Limitations
Few trials, high risk of bias, short follow-up.
Supplements Studied
Evidence for complementary and alternative treatments of recurrent vulvovaginal candidiasis is of low certainty.
Outcomes Measured
Antifungal maintenance regimens reduce recurrence of vulvovaginal candidiasis, but evidence for complementary treatments is low certainty.
Antifungal maintenance regimens reduce recurrence of vulvovaginal candidiasis, but evidence for complementary treatments is low certainty.
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.